The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years.
Marc D S MoncrieffBeverly UnderwoodJennifer J GariochMartin HeatonNakul PatelEsther BastiaannetJosette E H M Hoekstra-WeebersHarald J HoekstraPublished in: Annals of surgical oncology (2020)
The UK 3-year data were consistent with the previous Dutch report. The reduced follow-up strategy was shown to be safe, with significant resource usage benefits for national cancer services. Patient anxiety levels were not increased by a less-intensive follow-up regimen, and acceptance was high. The study data indicate that patient self-examination is very effective for recurrence detection.
Keyphrases
- end stage renal disease
- healthcare
- primary care
- case report
- newly diagnosed
- electronic health record
- ejection fraction
- chronic kidney disease
- mental health
- big data
- cross sectional
- prognostic factors
- machine learning
- peritoneal dialysis
- patient reported outcomes
- depressive symptoms
- health insurance
- basal cell carcinoma